| Returns | 1W : -4.8% , 1M : -1.2%,1Y : 67.8% | www.divislabs.com |
| Peers & Returns | 1W | 1M | 1Y |
| DIVIS LABORATORIES | -4.8% | -1.2% | 67.8% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.7% | 5.6% | 69.1% |
| DR REDDYS LABORATORIES | -4.9% | -4.4% | -8% |
| CIPLA | -0.9% | -7.1% | 19.3% |
| GLAND PHARMA | -1.5% | -4.6% | NA |
| PIRAMAL ENTERPRISES | -8.1% | -2% | 102.9% |
| CADILA HEALTHCARE | -6% | -10.5% | 20.8% |
| TORRENT PHARMACEUTICALS | -4.6% | -3.9% | 12.5% |
| ALKEM LABORATORIES | -3% | -3.7% | 42.9% |
| Ratio | Consolidated |
|---|---|
|
P/E P/B P/S |
68.01
P/E Calculated based on EPS of 74.75
[ Mar2021 - Consolidated Results ] 14.52
P/B Calculated based on Book Value of 350.15
[ Mar2021 - Consolidated Results ] 18.75
P/S Calculated based on Revenues of 7199.57 Cr
[ TTM - Consolidated Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
148% 149% 159% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2021 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SENSEX50 | -2% | 3.1% | 54.5% |
| S&P BSE LARGECAP | -2.3% | 3.1% | 55% |
| S&P BSE 100 LARGECAP TMC | -2.4% | 2.8% | 55.6% |
| S&P BSE 100 ESG INDEX | -2.5% | 3.5% | 55.9% |
| S&P BSE 100 | -2.5% | 2.8% | 55.9% |
| S&P BSE CARBONEX | -2.5% | 3.2% | 55.8% |
| S&P BSE LARGE MIDCAP | -2.7% | 2.9% | 57.9% |
| S&P BSE 200 | -2.7% | 2.8% | 58.9% |
| S&P BSE 250 LARGEMIDCAP | -2.9% | 2.7% | 59.4% |
| S&P BSE 500 | -3.1% | 2.7% | 61.2% |
| S&P BSE ALLCAP | -3.2% | 2.7% | 62.3% |
| S&P BSE DIVIDEND STABILITY | -3.8% | 6.3% | 65% |
| S&P BSE LOW VOLATILITY | -4.4% | -3.2% | 39.7% |
| S&P BSE HEALTHCARE | -4.4% | -5% | 27.9% |
| S&P BSE MOMENTUM | -5% | 5.4% | 53.9% |
| MFG | -5% | 1.6% | 49.9% |
| S&P BSE QUALITY | -5.1% | 1.2% | 49.6% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 100 ALPHA 30 | -1.3% | 2.6% | NA |
| NIFTY 50 | -2% | 3.2% | 54.5% |
| NIFTY 100 | -2.4% | 2.6% | 55.1% |
| NIFTY LARGE MIDCAP 250 | -2.4% | 4.3% | 70.8% |
| NIFTY500 MULTICAP 50:25:25 | -2.5% | 4.2% | NA |
| NIFTY 200 | -2.8% | 2.8% | 58.7% |
| NIFTY 500 | -3.1% | 2.7% | 60.9% |
| NIFTY ALPHA QTY VAL LOW-VOL 30 | -3.5% | -2.4% | 44.9% |
| NIFTY QUALITY LOW-VOLATILTY 30 | -3.5% | -1.4% | 44% |
| NIFTY ALPHA QTY LOW-VOLAT.30 | -3.5% | -2.2% | 45.6% |
| NIFTY HEALTHCARE | -3.7% | -3.1% | NA |
| NIFTY 100 EQUAL WEIGHT | -3.9% | 1.1% | 66.8% |
| NIFTY200 QUALITY30 | -4.2% | -3.3% | 42.2% |
| NIFTY PHARMA | -4.4% | -2.7% | 19.9% |
| NIFTY ALPHA LOW-VOLATILTY 30 | -4.9% | -4.3% | 42.5% |
|
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD Quarterly Results of DR REDDYS LABORATORIES LTD Quarterly Results of CIPLA LTD Quarterly Results of GLAND PHARMA LTD |
|
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD Market Cap of DR REDDYS LABORATORIES LTD Market Cap of CIPLA LTD Market Cap of GLAND PHARMA LTD |
#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014
Contact Us
support@smart-investing.in
Smart-Investing.in
Pricing
Video Course
Blog
Tools
Screener
Compare
Analyze Portfolio
© 2019 - 2021 Smart-Investing.in. All rights reserved. Built with ❤️ in India
Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed.
We don't make any Buy/Sell recommendations and don't give any price targets.
This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only.
Please do your own research before making any investment decisions.
Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose. Past Performance is not indicative of future returns.
We have affiliate relationships with Amazon and Zerodha.
Financial Data Source: Accord Fintech |
Methodology |
Privacy Policy |
Terms & Conditions |
SEBI Registered Research Analyst Registration No : INH000007377 |
Disclosure